US Patent Issued to Incyte on July 28 for "Tricyclic triazolo compounds as DGK inhibitors" (Delaware, Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,276, issued on July 28, was assigned to Incyte Corp. (Wilmington, Del.).

"Tricyclic triazolo compounds as DGK inhibitors" was invented by Joshua Hummel (Hockessin, Del.), Liana Hie (Wilmington, Del.), Jacob J. Lacharity (Chesterbrook, Pa.), Sharada Manns (Wilmington, Del.), Ding-Quan Qian (Newark, Del.) and Xiaozhao Wang (Moorestown, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides tricyclic triazolo compounds that modulate the activity of diacylglycerol kinase (DGK), which are useful in the treatment of various diseases, including cancer."

The patent was filed on June 7, 2023, under Application No. 18/330,623. ...